BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 31867746)

  • 1. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
    Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
    J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
    Huang J; Wang X; Zhu Y; Wang Z; Li J; Xu D; Wang S; Li TE; Lu L
    J Surg Oncol; 2019 Jan; 119(1):40-46. PubMed ID: 30480811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcomatoid intrahepatic cholangiocarcinoma in a patient with poor prognosis: a case report and literature review.
    Li X; Li J; Liu K; Tan L; Liu Y
    J Int Med Res; 2020 Nov; 48(11):300060520969473. PubMed ID: 33161814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic Cholangiocarcinoma in the Liver Explant After Liver Transplantation: Histological Differentiation and Prognosis.
    Takahashi K; Obeid J; Burmeister CS; Bruno DA; Kazimi MM; Yoshida A; Abouljoud MS; Schnickel GT
    Ann Transplant; 2016 Apr; 21():208-15. PubMed ID: 27068242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.
    Yeh CN; Wang SY; Chen YY; Chen MH; Chiang KC; Cheng CT; Tsai CY; Wang CC; Yeh TS; Chen TC
    Anticancer Res; 2016 Aug; 36(8):4249-58. PubMed ID: 27466540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
    Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V
    J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
    Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
    BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
    Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
    Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
    Rhee H; Kim MJ; Park YN; An C
    Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma.
    Öztürk NB; Jamil LH
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):766-774. PubMed ID: 38683193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.
    Jing CY; Fu YP; Shen HJ; Zheng SS; Lin JJ; Yi Y; Huang JL; Xu X; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Oncotarget; 2017 Feb; 8(8):13293-13303. PubMed ID: 28076328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
    Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence.
    Chan KM; Tsai CY; Yeh CN; Yeh TS; Lee WC; Jan YY; Chen MF
    BMC Gastroenterol; 2018 Dec; 18(1):180. PubMed ID: 30514231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: A prospective cohort study.
    Deng L; Wang Y; Zhao J; Tong Y; Zhang S; Jin C; Chen K; Bao W; Yu Z; Chen G
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):603-612. PubMed ID: 32933804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
    Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
    Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the AJCC 8th Edition Staging System for Pathologically Versus Clinically Staged Intrahepatic Cholangiocarcinoma (iCCA): a Time to Revisit a Dogma? A Surveillance, Epidemiology, and End Results (SEER) Analysis.
    Kamarajah SK
    J Gastrointest Cancer; 2019 Sep; 50(3):392-399. PubMed ID: 29512000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma.
    Bagante F; Merath K; Squires MH; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    J Gastrointest Surg; 2018 Mar; 22(3):477-485. PubMed ID: 29352440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma.
    Xiao Y; Zhou C; Ni X; Huang P; Wu F; Yang C; Zeng M
    Cancer Imaging; 2023 Feb; 23(1):15. PubMed ID: 36782276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma.
    Wang T; Wang W; Zhang J; Yang X; Shen S; Wang W
    Front Oncol; 2020; 10():598433. PubMed ID: 33363028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study.
    Chen B; Mao Y; Li J; Zhao Z; Chen Q; Yu Y; Yang Y; Dong Y; Lin G; Yao J; Lu M; Wu L; Bo Z; Chen G; Xie X
    Comput Biol Med; 2023 Dec; 167():107612. PubMed ID: 37939408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.